Nucynta Ir 50 mg (Tapentadol (Tapentadol Hydrochloride) TABLET (IMMEDIATE RELEASE)) 50 MG

NUCYNTA IR 50 MG tablets contain tapentadol hydrochloride, an opioid analgesic for pain management. This immediate-release formulation is designed for oral administration and is commonly used for moderate to severe pain relief.

Strength

50 MG

Pack Size

100

Manufacturer / TM Owner

ENDO OPERATIONS LTD.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

NUCYNTA IR 50 MG tablets are primarily used for the management of moderate to severe pain. Tapentadol, the active ingredient, is an opioid analgesic that works by affecting the central nervous system. This medication is often prescribed for conditions that require immediate pain relief, such as acute pain following surgery or injury. It is important to follow the guidance of a healthcare professional when considering the use of NUCYNTA IR 50 MG tablets.

Side Effects

Common effects of NUCYNTA IR 50 MG tablets may include dizziness, nausea, vomiting, and constipation. Some users may also experience drowsiness or headache. These effects can vary from person to person and may subside as the body adjusts to the medication. If any of these effects persist or worsen, it is advisable to consult a healthcare professional.

Precautions & Warnings

NUCYNTA IR 50 MG tablets should be handled with care. They should be stored in a cool, dry place away from direct sunlight and out of reach of children. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. Do not exceed the recommended dose unless directed by a healthcare provider.

Avoid Interactions

NUCYNTA IR 50 MG tablets may interact with other medications, including alcohol, antidepressants, and other opioids. Combining these tablets with alcohol or other central nervous system depressants can increase the risk of severe side effects. It is crucial to inform your healthcare provider about all medications you are taking to avoid potential interactions.

Frequently Asked Questions

NUCYNTA IR 50 MG tablets are used for the management of moderate to severe pain. They are designed to provide immediate pain relief.

NUCYNTA IR 50 MG tablets are taken orally, typically with or without food. Follow the dosage instructions provided by your healthcare professional.

Common side effects may include dizziness, nausea, vomiting, and constipation. Some users may also experience drowsiness or headache.

NUCYNTA IR 50 MG may interact with other medications, including alcohol and antidepressants. Consult your healthcare provider before combining it with other drugs.

Store NUCYNTA IR 50 MG tablets in a cool, dry place away from direct sunlight and out of reach of children.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.